Additional Information

Description

Palonosetron 0.25 mg/5 mL SDV is an antiemetic medication indicated for the prevention of nausea and vomiting associated with chemotherapy and postoperative procedures. It belongs to the class of 5-HT3 receptor antagonists, which specifically block serotonin receptors in the central nervous system and gastrointestinal tract.

Administered via intravenous injection, Palonosetron is effective in both acute and delayed phases of chemotherapy-induced nausea and vomiting. The formulation is presented in a single-dose vial (SDV) containing 0.25 mg of the active ingredient in 5 mL of solution.

Clinical studies have demonstrated the efficacy of Palonosetron in providing effective control of nausea and vomiting, contributing to improved patient comfort and quality of life during cancer treatment. Its prolonged half-life allows for dosing flexibility, making it a suitable choice for various chemotherapy regimens.

Storage requirements for Palonosetron include keeping the solution at controlled room temperature, protected from light. As with all medications, healthcare providers should monitor patients for potential side effects, which may include headache and constipation.